In a 79-year-old woman with chronic kidney disease and eGFR 28 mL/min/1.73 m² who is on nitrofurantoin (Macrobid) for a presumed urinary tract infection despite a urinalysis showing moderate leukocyte esterase and bacteria but no white blood cells, negative nitrite, and a culture with no growth, and who presents with weakness, poor appetite, and is receiving normal saline at 50 mL/h, should the nitrofurantoin be discontinued and the patient be monitored clinically?

Discontinue Nitrofurantoin Immediately

Yes, discontinue the nitrofurantoin immediately and monitor clinically—this patient does not have a urinary tract infection and the medication is both inappropriate for her renal function and potentially contributing to her symptoms.

Why This Patient Does Not Have a UTI

This clinical picture represents asymptomatic bacteriuria (ABU), not a true UTI. The most recent 2024 European Urology guidelines are explicit about this scenario 1:

• No fever, no urinary symptoms (no dysuria, frequency, urgency, or suprapubic pain)
• Negative nitrite AND no WBCs on microscopy despite positive leukocyte esterase
• Negative urine culture (no growth)
• Presenting symptoms (weakness, poor appetite) are nonspecific and not localizing to the urinary tract

The 2024 guidelines specifically state: "NO ANTIBIOTICS for urinary tract infection" when patients lack recent-onset dysuria, frequency, urgency, or systemic signs (fever, rigors, delirium) UNLESS urinalysis shows negative nitrite AND negative leukocyte esterase 1. This patient's UA showed moderate leukocyte esterase but negative nitrite and no actual WBCs on microscopy, combined with no growth on culture—this definitively rules out UTI.

The 2019 IDSA guidelines on asymptomatic bacteriuria reinforce this: in older patients with bacteriuria and nonspecific symptoms like weakness or decreased appetite without local genitourinary symptoms, the recommendation is "assessment for other causes and careful observation rather than antimicrobial treatment" 2.

Nitrofurantoin is Contraindicated at This eGFR

Nitrofurantoin is contraindicated with eGFR 28 mL/min/1.73 m² according to FDA labeling 3:

• The FDA label explicitly states: "Anuria, oliguria, or significant impairment of renal function (creatinine clearance under 60 mL per minute or clinically significant elevated serum creatinine) are contraindications" 3
• The 2014 KDOQI guidelines don't specifically address nitrofurantoin dosing, but emphasize careful medication management in CKD 4

The Evidence on Efficacy and Safety

While some research suggests nitrofurantoin may retain efficacy down to eGFR 30-40 mL/min 5, 6, 7, the safety concerns are paramount at eGFR 28:

• A 2013 Dutch study found that renal impairment <50 mL/min was associated with a 4-fold increased risk of pulmonary adverse events requiring hospitalization (HR 4.1,95% CI 1.31-13.09) 8
• The FDA label warns that elderly patients have higher rates of pulmonary reactions including fatalities with nitrofurantoin, and that "the risk of toxic reactions may be greater in patients with impaired renal function" 3
• At eGFR 28, this patient is at Stage 4 CKD (G4), well below the 60 mL/min threshold and even below the 30-40 mL/min range where limited data suggest possible efficacy

Nitrofurantoin May Be Causing Her Symptoms

Nitrofurantoin can cause anorexia, nausea, and gastrointestinal symptoms 3. In a 79-year-old with poor appetite and weakness:

• The temporal relationship (symptoms while on medication) suggests drug effect
• Discontinuation may lead to symptom resolution
• The FDA label lists nausea and anorexia as known adverse effects 3

Clinical Management Algorithm

Immediate actions:

1. Stop nitrofurantoin immediately
2. Continue IV hydration (NS at 50 mL/hr is appropriate for her age and renal function)
3. Monitor for symptom improvement over 24-48 hours after stopping the antibiotic

Evaluate alternative causes of weakness and poor appetite:

• Dehydration (you're already addressing this)
• Electrolyte abnormalities
• Medication effects from other drugs
• Underlying illness unrelated to UTI
• Nutritional deficiencies

Do NOT treat for UTI:

• No antibiotics needed—she doesn't have an infection
• The negative culture confirms this
• Treating ABU in elderly patients increases antimicrobial resistance and C. difficile risk without benefit 2

Common Pitfalls to Avoid

1. Don't confuse pyuria or positive leukocyte esterase with UTI in elderly patients—ABU is extremely common and the specificity of UA is only 20-70% in this population 1

2. Don't attribute nonspecific symptoms to UTI without localizing signs—weakness and poor appetite have broad differential diagnoses 2

3. Don't continue antibiotics "just to finish the course" when they're inappropriate—stopping immediately prevents further harm 3

4. Don't use nitrofurantoin at eGFR <30 mL/min—the contraindication exists for good reason despite some conflicting research 3, 8